• COVID-19 Resources
  • About
  • Subscribe
  • Promotions
  • Advertise
  • Contact Us
  • June 2, 2025

Milwaukee Courier Weekly Newspaper

"THE NEWSPAPER YOU CAN TRUST SINCE 1964"

  • News
  • Editorials
  • Education
  • Urban Business
  • Health
  • Religion
  • Upcoming Events
  • Classifieds
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MILWAUKEE COURIER

Share:

  • Click to share on Facebook (Opens in new window) Facebook
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

340B Doesn’t Solve Health Inequities

December 23, 2022

By Amy Hinojosa

Amy Hinojosa

Advocates have long fought for federal funding to reach people in most need. Back in 1992, Congress established the 340B drug pricing program, which guaranteed drug discounts to hospitals serving a disproportionately high percentage of uninsured or low-income patients.

Congress hoped the legislation would help hospitals provide better, less expensive care. But the enabling legislation and subsequent implementing regulations did too little to ensure that outcome. Instead, hospitals and clinics are wielding 340B against the very people lawmakers wanted to help.

That’s because federal law doesn’t require hospitals to reinvest their 340B savings in vulnerable communities. Instead, many of these facilities charge patients top dollar while keeping the discounts for themselves.

Take for example, Bon Secours Mercy Health — a nonprofit hospital chain — that raked in almost $1 billion in profits last year, according to a recent New York Times report.

Federal law actually makes it easy for hospitals to rip off their most vulnerable patients while directing inordinate resources to high-income, largely white communities. It’s time for Congress to put an end to this flourishing scam by revising the law that makes it possible.

Congress must address the fact that numerous facilities that don’t actually serve low-income communities qualify for 340B. Clinics belonging to the same hospital chain as a disproportionate-share facility can often register for the program — even if their clientele is generally well-off, with good insurance.

Unsurprisingly, hospitals and clinics have signed up in droves for the free money. The total number of participating facilities surged from 8,100 to 50,000 between 2000 and 2020. More and more of them are located in high-income areas — which means wealthy communities are benefiting from a program intended for the underprivileged.

As of 2021, uninsured patients made up about 9% of the U.S. population. These are exactly the marginalized groups, often racial minorities, the 340B discounts were supposed to help. Instead, these patients face the prospect of hospital bills of hundreds or even thousands of dollars for a single drug.

Cancer treatment, for example, has become a massive money-maker. According to a recent analysis from the Community Oncology Alliance, disproportionate-share hospitals often sell their top oncology drugs at 4.9 times the discounted 340B acquisition price.

For one drug, the average markup was 11.3 times the discounted cost.

Meanwhile, about three quarters of private nonprofit hospitals earn more through tax breaks than they expend in charity and community investment. The Lown Institute Hospitals Index found that in 2019, the value of the nonprofit tax breaks enjoyed by 227 private nonprofit hospital systems totaled $18.4 billion more than those systems spent on “charity care and community investment.”

Disparities like these won’t end until Congress enforces its supposed intention to create a program that actually helps low-income communities. Today, the 340B program does no such thing.

Amy Hinojosa is the president and CEO of MANA, a national Latina organization, the oldest and largest Latina membership organization in the United States and founding member of the Health Equity Collaborative. A longer version of this piece originally ran in the Richmond Times-Dispatch.

Share:

  • Click to share on Facebook (Opens in new window) Facebook
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Popular Interests In This Article: 340B, Amy Hinojosa, Prescription Drug Prices

Read More - Related Articles

  • Senator Baldwin Applauds Announcement of 15 More Prescription Drugs to be Negotiated for Lower Prices
  • White House Celebrates Record ACA Enrollment as Trump Administration Plans to Overhaul Health Care
  • Milwaukee County Executive David Crowley and Congresswoman (D-VA) Jennifer McClellan Host Roundtable Event on Kamala Harris’s Efforts to Lower Medical Costs
  • Biden and Harris Reunite to Highlight Drug Pricing Deal
  • Congress Listens, Avoids Damaging Prescription Drug Market
Become Our Fan On Facebook
Find Us On Facebook


Follow Us On X
Follow Us On X

Editorials

Lakeshia Myers
Michelle Bryant
Dr. Kweku Akyirefi Amoasi formerly known as Dr. Ramel Smith

Journalists

Karen Stokes

Topics

Health Care & Wellness
Climate Change
Upcoming Events
Obituaries
Milwaukee NAACP

Politicians

David Crowley
Cavalier Johnson
Marcelia Nicholson
Governor Tony Evers
President Joe Biden
Vice President Kamala Harris
Former President Barack Obama
Gwen Moore
Milele A. Coggs
Spencer Coggs

Classifieds

Job Openings
Bid Requests
Req Proposals
Req Quotations
Apts For Rent

Contact Us

Milwaukee Courier
2003 W. Capitol Dr.
Milwaukee, WI 53206
Ph: 414.449.4860
Fax: 414.906.5383

Copyright © 2025 · Courier Communications | View Privacy Policy | Site built and maintained by Farrell Marketing Technology LLC
We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.